Scarica l'app Stockscreener
5.88
10.64%
-0.70
Dopo l'orario di chiusura:
6.02
0.14
+2.38%
Precedente Chiudi:
$6.58
Aprire:
$6.4
Volume 24 ore:
8,260
Relative Volume:
0.20
Capitalizzazione di mercato:
$38.70M
Reddito:
-
Utile/perdita netta:
$-31.48M
Rapporto P/E:
-5.6538
EPS:
-1.04
Flusso di cassa netto:
$-28.71M
1 W Prestazione:
-28.29%
1M Prestazione:
-18.45%
6M Prestazione:
+17.13%
1 anno Prestazione:
-67.78%
Intervallo 1D:
$5.78
$6.40
Intervallo di 1 settimana:
$5.78
$9.04
Portata 52W:
$4.11
$28.68
Forte Biosciences Inc Stock (FBRX) Company Profile
Nome
Forte Biosciences Inc
Settore
Industria
Telefono
(310) 618-6994
Indirizzo
3060 PEGASUS PARK DRIVE, DALLAS, CA
Confronta FBRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
5.88 | 38.70M | 0 | -31.48M | -28.71M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-21 | Iniziato | TD Cowen | Buy |
| 2024-04-08 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | Aggiornamento | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | Downgrade | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | Downgrade | Truist | Buy → Hold |
| 2021-05-14 | Iniziato | B. Riley Securities | Buy |
| 2021-03-26 | Iniziato | Citigroup | Buy |
| 2020-08-28 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | Iniziato | Truist | Buy |
Mostra tutto
Forte Biosciences Inc Borsa (FBRX) Ultime notizie
All You Need to Know About Forte Biosciences (FBRX) Rating Upgrade to Buy - Yahoo Finance
Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World
Chardan Capital Issues Pessimistic Forecast for Forte Biosciences (NASDAQ:FBRX) Stock Price - Defense World
Chardan Adjusts Price Target on Forte Biosciences to $61 From $64, Maintains Buy Rating - MarketScreener
Forte Biosciences Reports 2024 Progress and Financials - TipRanks
Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Forte's Celiac Treatment Shows Promise: Zero Dropouts and $58.4M War Chest - Stock Titan
Forte Biosciences, Inc. Announces Results and Provides Clinical Update - Bluefield Daily Telegraph
Forte Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Forte Biosciences Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - MarketScreener
Forte Biosciences, Inc. SEC 10-K Report - TradingView
Forte Biosciences Inc. (FBRX) reports earnings - Quartz
(FBRX) Long Term Investment Analysis - news.stocktradersdaily.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
FORTE BIOSCIENCES Earnings Preview: Recent $FBRX Insider Trading, Hedge Fund Activity, and More - Nasdaq
Forte Biosciences (FBRX) to Release Earnings on Monday - The AM Reporter
Forte Biosciences Inc expected to post a loss of $3.27 a shareEarnings Preview - TradingView
Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Large Drop in Short Interest - Defense World
Forte Biosciences (FBRX) Expected to Announce Quarterly Earnings on Monday - Defense World
Stock Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - The AM Reporter
Traders Purchase High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World
Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update - MarketBeat
Forte Biosciences Stock Down 20% But Insiders Still In US$92k Profit - Simply Wall St
Pre-market Movers: ISPC, TH, IVVD, TOVX... - RTTNews
(FBRX) On The My Stocks Page - news.stocktradersdaily.com
Stock Traders Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat
Evelo Biosciences Target of Unusually Large Options Trading (NASDAQ:EVLO) - Defense World
One Forte Biosciences Insider Raised Stake By 273% In Previous Year - Yahoo Finance
Best Stocks Under $20 Right Now - Benzinga
Where are the Opportunities in (FBRX) - Stock Traders Daily
Stock Traders Buy High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings -February 03, 2025 at 09:03 am EST - Marketscreener.com
Autoimmune Biotech Forte Lines Up Strategic Presentations at Major Healthcare Investment Forums - Stock Titan
(FBRX) Proactive Strategies - Stock Traders Daily
CSG Forte Wins TSG Real Transaction Metrics Awards for Second Consecutive Year - Yahoo Finance
Forte Biosciences expands equity incentive plan By Investing.com - Investing.com Australia
TD Cowen initiates Forte Biosciences stock with Buy rating - MSN
Forte Biosciences expands equity incentive plan - MSN
Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World
Meiwu Technology (NYSE:WNW) Stock Price Down 13.2% – Here’s Why - Defense World
Forte Biosciences (NASDAQ:FBRX) Coverage Initiated by Analysts at TD Cowen - Defense World
TD Cowen initiates Forte Biosciences stock with Buy rating By Investing.com - Investing.com Australia
Atopic Dermatitis Drugs Market Trends Analysis Report - GlobeNewswire
(FBRX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX) - Defense World
Forte Biosciences (FBRX) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
(FBRX) Technical Data - Stock Traders Daily
Investors Purchase Large Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO) - Defense World
Investors Buy High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World
100 cell and gene therapy leaders to watch in 2025 - Drug Discovery & Development
Forte Biosciences Inc Azioni (FBRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):